Cargando…
The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y(12) Pathway in Multiple Sclerosis
Epidemiological studies confirm a high risk of ischemic events in secondary-progressive multiple sclerosis (SP MS) patients, directly associated with an increased level of pro-thrombotic activity of platelets. Our work aimed to verify potential molecular abnormalities of the platelet P2Y(12) recepto...
Autores principales: | Dziedzic, Angela, Miller, Elzbieta, Saluk-Bijak, Joanna, Niwald, Marta, Bijak, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234174/ https://www.ncbi.nlm.nih.gov/pubmed/34207429 http://dx.doi.org/10.3390/ijms22126572 |
Ejemplares similares
-
Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019) -
Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2017) -
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020) -
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020) -
The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)